Full-Time

Manager – Portfolio Strategy and Management

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Senior

Chicago, IL, USA

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Product Management
Requirements
  • 5+ years of experience in a strategic business function such as corporate strategy, management consulting, private equity, and/or product management
  • 3+ years of experience in the healthcare and/or life sciences sector
  • Excellent verbal and written communication skills
  • Entrepreneurial mindset and comfort with ambiguity
  • Solutions-oriented and bias to action
Responsibilities
  • Develop long-term portfolio vision, strategy and roadmap for Tempus’ tissue biopsy products, based on analysis of customer needs, competitive landscape, internal feasibility, and financial and strategic value. Deliverables may include:
  • 3-5 year business roadmaps, prioritizing new product and other business growth opportunities
  • Target product profiles (TPPs)
  • Commercialization and lifecycle management plans
  • Collaborate with cross-functional leadership (sales, marketing, market access, medical, product, R&D, etc.) to deliver on business goals for the liquid biopsy portfolio
  • Ensure appropriate resource availability and prioritization
  • Constantly evaluate trade-off decisions to ensure product development speed, efficiency, and quality
  • Develop launch strategies to guide new product launch planning
  • Proactively monitor competitive intelligence and customer feedback to identify and act on new threats and opportunities
  • Lead cross-functional annual planning process for the liquid portfolio

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing actionable insights from medical images and identifying gaps in patient care. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Additionally, Tempus conducts significant research, particularly in cancer, and has developed a pan-cancer organoid platform for precision medicine, along with a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

13%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with JW Pharmaceutical enhances drug development using AI-driven insights.
  • Launch of Olivia app expands personal health management and patient engagement.
  • Acquisition of Ambry Genetics expands capabilities in medical diagnostics and testing.

What critics are saying

  • Ambry Genetics acquisition may strain financial resources and integration capabilities.
  • Collaboration with Flatiron Health may face data compatibility and integration challenges.
  • Immune Profile Score test may face regulatory scrutiny, delaying its adoption.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and treatment effectiveness.
  • Tempus focuses on cancer research, enhancing personalized therapeutic opportunities for patients.

Help us improve and share your feedback! Did you find this helpful?